Matches in Nanopublications for { ?s ?p "[Immunohistochemical analysis demonstrated that FLIP and TRAIL-R2 were significantly higher expressed in anaplastic (WHO grade III) than in diffuse (WHO grade II) gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP300785.RAwicB3qYjvAMMYkw_0egnElR048eoDivgN7Q9hAghryc130_assertion description "[Immunohistochemical analysis demonstrated that FLIP and TRAIL-R2 were significantly higher expressed in anaplastic (WHO grade III) than in diffuse (WHO grade II) gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300785.RAwicB3qYjvAMMYkw_0egnElR048eoDivgN7Q9hAghryc130_provenance.
- NP643898.RA9df0DBDD7tTTVSIpN9375mMe8vccUreaR-CuiHiTJu8130_assertion description "[Immunohistochemical analysis demonstrated that FLIP and TRAIL-R2 were significantly higher expressed in anaplastic (WHO grade III) than in diffuse (WHO grade II) gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643898.RA9df0DBDD7tTTVSIpN9375mMe8vccUreaR-CuiHiTJu8130_provenance.
- NP807255.RATTw2S6_Uim_F0iJf74Bx_TQ45h22jb28idmfwjt84l8130_assertion description "[Immunohistochemical analysis demonstrated that FLIP and TRAIL-R2 were significantly higher expressed in anaplastic (WHO grade III) than in diffuse (WHO grade II) gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807255.RATTw2S6_Uim_F0iJf74Bx_TQ45h22jb28idmfwjt84l8130_provenance.
- assertion description "[Immunohistochemical analysis demonstrated that FLIP and TRAIL-R2 were significantly higher expressed in anaplastic (WHO grade III) than in diffuse (WHO grade II) gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Immunohistochemical analysis demonstrated that FLIP and TRAIL-R2 were significantly higher expressed in anaplastic (WHO grade III) than in diffuse (WHO grade II) gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP715786.RAirnGMeIZR9mPVQnObpevq_2S91kmI616e-gHLbir1gQ130_assertion description "[Immunohistochemical analysis demonstrated that FLIP and TRAIL-R2 were significantly higher expressed in anaplastic (WHO grade III) than in diffuse (WHO grade II) gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715786.RAirnGMeIZR9mPVQnObpevq_2S91kmI616e-gHLbir1gQ130_provenance.
- NP805723.RAKloWVXXk6GkNgcRCnQaYRbs7cSVGq1Z_DnXJM5VOkl4130_assertion description "[Immunohistochemical analysis demonstrated that FLIP and TRAIL-R2 were significantly higher expressed in anaplastic (WHO grade III) than in diffuse (WHO grade II) gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805723.RAKloWVXXk6GkNgcRCnQaYRbs7cSVGq1Z_DnXJM5VOkl4130_provenance.
- NP715784.RA76TUMfKimY-gm1JM6IP9pZU9NNbrwudF_ahqz2YKj1w130_assertion description "[Immunohistochemical analysis demonstrated that FLIP and TRAIL-R2 were significantly higher expressed in anaplastic (WHO grade III) than in diffuse (WHO grade II) gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715784.RA76TUMfKimY-gm1JM6IP9pZU9NNbrwudF_ahqz2YKj1w130_provenance.